Skip to main content

Sodium Fluoride F 18

Generic: SODIUM FLUORIDE F-18

Verified·Apr 23, 2026
Manufacturer
Petnet
NDC
62072-500
Route
INTRAVENOUS
ICD-10 indication
R93.6

Affordability Check

How much will you actually pay for Sodium Fluoride F 18?

In 30 seconds, see every legitimate way to afford Sodium Fluoride F 18 — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.

Check my options →

About Sodium Fluoride F 18

What is this medication? Sodium Fluoride F 18 is a radioactive diagnostic agent used in medical imaging, specifically in positron emission tomography or PET scans. It is classified as a radiopharmaceutical that allows doctors to visualize the skeletal system by identifying areas of altered bone turnover. Once administered into the body, the substance is absorbed by the bones, concentrating in locations where there is high osteoblastic activity, which indicates bone formation or repair.

This medication is most commonly used to detect and evaluate bone metastases in patients with known or suspected cancer. It helps clinicians identify sites where cancer may have spread to the skeleton, providing a clearer picture of the disease's progression compared to some traditional imaging methods. In addition to oncology, it can be used to assess various other skeletal conditions that involve abnormal bone metabolism, helping medical teams determine the most effective course of treatment for their patients.

Copay & patient assistance

Detailed copay and financial assistance information is not publicly available for this medication at this time. Please consult your pharmacist or the manufacturer's official patient support program for more details.

External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.

Compare pricing elsewhere

RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.

We deep-link because transparency helps patients. None of these partners pay RxCopays.

Prescribing information

From the FDA-approved label for Sodium Fluoride F 18. Official source: DailyMed (NLM) · Label effective Jan 27, 2026

Adverse reactions
6 ADVERSE REACTIONS No adverse reactions have been reported for Sodium Fluoride F 18 Injection based on a review of the published literature, publicly available reference sources, and adverse drug reaction reporting systems. However, the completeness of these sources is not known. No adverse reactions have been reported for Sodium Fluoride F 18 Injection based on a review of the published literature, publicly available reference sources, and adverse drug reaction reporting systems (6) . To report SUSPECTED ADVERSE REACTIONS, contact Kreitchman PET Center at 1-212-305-0081 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

Label text is reproduced as-is from the FDA-approved label. We do not paraphrase, summarize, or omit. Content above is for informational purposes only and is not medical advice. Always consult your prescribing clinician or pharmacist before making decisions about your medication.

Conditions we've indexed resources for

Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.

Prior authorization & coverage

PayerPAStep therapyCopay tier

Medicare Part D

Related drugs

How this page is sourced

  • Drug identity verified against openFDA NDC Directory.
  • Label text (when shown) originates from NLM DailyMed.
  • Copay and assistance URLs verified periodically; if you hit a broken link, tell us.